96 results
Page 3 of 5
8-K
EX-10.1
fsra wqizul
13 Jun 19
Departure of Directors or Certain Officers
4:58pm
8-K
qg4imslwon3384cjnn
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm
DEFM14A
pz64nm3w
6 Nov 18
Proxy related to merger
12:00am
424B3
8ftdii
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
jbda09
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-3.1
f0ngsi24
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.1
nmneqi4w1mkowc
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
gz71w7m
9 Aug 18
Business combination disclosure
5:17pm
425
EX-3.1
ilolt 04onvqmf
9 Aug 18
Business combination disclosure
5:17pm
8-K
EX-3.1
dhro9zrvb2q
23 Dec 16
OvaScience Announces Business Update
12:00am
8-K
0uzo2a 93xtz4ue7c3ms
23 Dec 16
OvaScience Announces Business Update
12:00am